Therapeutic challenges in a case of sarcoidosis

1. Ungprasert P, Ryu JH, Matteson EL. Clinical manifestations, diagnosis, and treatment of sarcoidosis. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 2019;3(3): 358–375. doi: 10.1016/j.mayocpiqo.2019.04.006.10.1016/j.mayocpiqo.2019.04.006671383931485575 Search in Google Scholar

2. Rao DA, Dellaripa PF. Extrapulmonary manifestations of sarcoidosis. Rheumatic Disease Clinics of North America. 2013;39(2): 277–297. doi: 10.1016/j.rdc.2013.02.007.10.1016/j.rdc.2013.02.007375666723597964 Search in Google Scholar

3. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. New England Journal of Medicine. 2007;357(21): 2153–2165. doi: 10.1056/NEJMra071714.10.1056/NEJMra07171418032765 Search in Google Scholar

4. Schilstra A, Rottoli P, Jacobs JA, van Suylen RJ, Galluzzi P, Drent M. Case studies to explore the pitfalls in the diagnosis of sarcoidosis. Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2006;23(2): 135–140. Search in Google Scholar

5. Lacomis D. Neurosarcoidosis. Current Neuropharmacology. 2011;9(3): 429–436. doi: 10.2174/157015911796557975.10.2174/157015911796557975315159722379457 Search in Google Scholar

6. Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. Journal of the American Academy of Dermatology. 2012;66: 699.e1–699.e18.10.1016/j.jaad.2011.11.96522507585 Search in Google Scholar

7. Herbort CP, Rao NA, Mochizuki M; Members of Scientific Committee of First International Workshop on Ocular Sarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocular Immunology and Inflammation. 2009;17(3): 160–169.10.1080/0927394090281886119585358 Search in Google Scholar

8. Mota PC, Morais A, Palmares C, Beltrão M, Melo N, Santos AC. Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis. Respiratory Medicine. 2012;106(7): 1014–1020.10.1016/j.rmed.2012.03.02022537923 Search in Google Scholar

9. Saidha S, Sotirchos ES, Eckstein C. Etiology of sarcoidosis: does infection play a role? Yale Journal of Biology and Medicine. 2012;85(1): 133–141. Search in Google Scholar

10. Ogisu N, Sato S, Kawaguchi H, Sugiura Y, Mori T, Niimi T. Elevated level of soluble HLA class I antigens in serum and bronchoalveolar lavage fluid in patients with sarcoidosis. Internal Medicine. 2001;40(3): 201–207.10.2169/internalmedicine.40.20111310485 Search in Google Scholar

11. Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. American Journal of Respiratory and Critical Care Medicine. 2020;201(8): 26–51. doi: 10.1164/rccm.202002-0251ST.10.1164/rccm.202002-0251ST715943332293205 Search in Google Scholar

12. Sehgal IS, Dhooria S, Aggarwal AN, Behera D, Agarwal R. Endosonography versus mediastinoscopy in mediastinal staging of lung cancer: systematic review and meta-analysis. Annals of Thoracic Surgery. 2016;102: 1747–1755.10.1016/j.athoracsur.2016.05.11027637288 Search in Google Scholar

13. Fritscher-Ravens A, Sriram PV, Topalidis T, Hauber HP, Meyer A, Soehendra N, et al. Diagnosing sarcoidosis using endosonography-guided fine-needle aspiration. Chest. 2000;118(4): 928–935. doi: 10.1378/chest.118.4.928. PMID: 11035658.10.1378/chest.118.4.92811035658 Search in Google Scholar

14. Judson MA. Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Reports. 2014;6: 89. doi: 10.12703/P6-89.10.12703/P6-89419127125374667 Search in Google Scholar

15. Valeyre D, Bernaudin JF, Uzunhan Y, Kambouchner M, Brillet PY, Soussan M, et al. Clinical presentation of sarcoidosis and diagnostic work-up. Seminars in Respiratory and Critical Care Medicine. 2014;35(3): 336–351. doi: 10.1055/s-0034-1381229.10.1055/s-0034-138122925007086 Search in Google Scholar

16. Li CW, Tao RJ, Zou DF, Li MH, Xu X, Cao WJ. Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China. BMJ Open. 2018;8: e18865. doi: 10.1136/bmjopen-2017-018865.10.1136/bmjopen-2017-018865582977929453299 Search in Google Scholar

17. Prosch H, Vonbank K, Loewe C, Beitzke D. Die vielen Gesichter der Sarkoidose. Der Radiologe. 2016;56(1): 77–89. doi: 10.1007/s00117-015-0063-9.10.1007/s00117-015-0063-926732655 Search in Google Scholar

18. Lee HN, Kim JI, Won K, Song R. Atypical CT findings of pulmonary sarcoidosis: A case report. Medicine (Baltimore). 2018;97(29): e11456. doi: 10.1097/MD.0000000000011456.10.1097/MD.0000000000011456608652330024519 Search in Google Scholar

19. Valeyre D, Bernaudin, JF, Jeny F, Duchemann B, Freynet O, Planès C, et al. Pulmonary sarcoidosis. Clinics in Chest Medicine 2015;36(4): 631–641.10.1016/j.ccm.2015.08.00626593138 Search in Google Scholar

20. Dziedzic DA, Peryt A, Orlowski T. The role of EBUS-TBNA and standard bronchoscopic modalities in the diagnosis of sarcoidosis. Clinical Respiratory Journal. 2017;11(1): 58–63. doi: 10.1111/crj.12304.10.1111/crj.1230425919969 Search in Google Scholar

21. Chapman S, Robinson G, Strandling J, West S, Wrightson J. Oxford Handbook of Respiratory Medicine. 3rd ed. United States of America: Oxford University Press; 2014.10.1093/med/9780198703860.003.0001 Search in Google Scholar

22. Carmona EM, Kalra S, Ryu JH. Pulmonary sarcoidosis: diagnosis and treatment. Mayo Clinic Proceedings. 2016:91(7): 946–954.10.1016/j.mayocp.2016.03.00427378039 Search in Google Scholar

23. Patel A, Bahna SL. Immediate hypersensitivity reactions to corticosteroids. Annals of Allergy, Asthma & Immunology. 2015:115(3): 178–182.10.1016/j.anai.2015.06.022 Search in Google Scholar

24. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999;54: 742–746.10.1136/thx.54.8.742 Search in Google Scholar

25. Vorselaars ADM, Wuyts WA, Vorselaars VMM, Zanen P, Deneer VHM, Veltkamp M. Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest. 2013:144(3): 805–812. doi: 10.1378/chest.12-1728.10.1378/chest.12-1728 Search in Google Scholar

26. Beegle SH, Barba K, Gobunsuy R, Judson MA. Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Design, Development and Therapy. 2013;7: 325–338. doi: 10.2147/DDDT.S31064.10.2147/DDDT.S31064 Search in Google Scholar

27. Popescu NA, Sheehan MG, Kouides PA, Loughner JE, Condemi JJ, Looney RJ, et al. Allergic reactions to cyclophosphamide: Delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients. Journal of Allergy and Clinical Immunology, 1996:97(1): 26–33. doi: 10.1016/s0091-6749(96)70279-8.10.1016/S0091-6749(96)70279-8 Search in Google Scholar

28. Boleto G, Vieira M, Desbois AC, Saadoun D, Cacoub P. Emerging molecular targets for the treatment of refractory sarcoidosis. Frontiers in Medicine, 2020:7: 594133. doi: 10.3389/fmed.2020.594133.10.3389/fmed.2020.594133773255233330556 Search in Google Scholar

29. Crommelin HA, Vorselaars AD, van Moorsel CH, Korenromp IH, Deneer VH, Grutters JC. Anti-TNF therapeutics for the treatment of sarcoidosis. Immunotherapy. 2014;6(10): 1127–1143. doi: 10.2217/imt.14.65.10.2217/imt.14.6525428650 Search in Google Scholar